Bacterial Endocarditis Global Clinical Trials Review, H1, 2017

2017-04-30
Price :
Published : Apr-2017
No. of Pages : 44
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Bacterial Endocarditis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Bacterial Endocarditis 30
Apr 21, 2017: Basilea announces agreement with FDA on Special Protocol Assessments for antibiotic ceftobiprole phase 3 clinical studies in bloodstream and skin infections 30
Clinical Trial Profile Snapshots 31
Appendix 41
Abbreviations 41
Definitions 41
Research Methodology 42
Secondary Research 42
About GlobalData 43
Contact Us 43
Source 44

List of Tables
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Bacterial Endocarditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Bacterial Endocarditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Bacterial Endocarditis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Bacterial Endocarditis Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
Bacterial Endocarditis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Bacterial Endocarditis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Bacterial Endocarditis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Bacterial Endocarditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Bacterial Endocarditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
Bacterial Endocarditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Bacterial Endocarditis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Bacterial Endocarditis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Bacterial Endocarditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Bacterial Endocarditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Bacterial Endocarditis Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
Bacterial Endocarditis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Bacterial Endocarditis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Bacterial Endocarditis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Bacterial Endocarditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Bacterial Endocarditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Bacterial Endocarditis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
Bacterial Endocarditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Bacterial Endocarditis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Bacterial Endocarditis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Bacterial Endocarditis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Bacterial Endocarditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 42
Filed in: Pharmaceutical
Publisher : GlobalData